Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Bardgett

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Topics in Behavioral Neurosciences|March 6, 2025
How Early-Life Antipsychotic Drug Administration Modifies Behavioral and Brain Function in AdulthoodMark E Bardgett
Neurobiology of Learning and Memory|May 7, 2002
Kainic acid lesions disrupt fear-mediated memory processingHenry Yin, Mark E Bardgett, John G Csernansky
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2002
The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppressionMark E Bardgett, William M Humphrey, John G Csernansky
Behavioral Neuroscience|April 1, 2009
Dopamine modulates effort-based decision making in ratsMark E Bardgett, Melissa Depenbrock, Nathan Downs, et al.
Neuropharmacology|July 13, 2010
The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in ratsMark E Bardgett, Megan Points, Jennifer Kleier, et al.
Neurobiology of Learning and Memory|November 16, 2010
Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's diseaseMark E Bardgett, Natasha N Davis, Patrick J Schultheis, et al.
Psychopharmacology|May 26, 2009
Effects of the H(3) antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in ratsMark E Bardgett, Megan Points, John Roflow, et al.
European Journal of Pharmacology|July 19, 2017
Early-life risperidone enhances locomotor responses to amphetamine during adulthoodBobbie Lee Stubbeman, Clifford J Brown, Justin R Yates, et al.
Alcoholism, Clinical and Experimental Research|June 17, 2011
Effects of energy drinks mixed with alcohol on behavioral control: risks for college students consuming trendy cocktailsCecile A Marczinski, Mark T Fillmore, Mark E Bardgett, et al.
Behavioural Pharmacology|March 10, 2016
Delayed yet persistent effects of daily risperidone on activity in developing ratsRachel M Stevens, Matthew A Gannon, Molly S Griffith, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Topics in Behavioral Neurosciences|March 6, 2025
How Early-Life Antipsychotic Drug Administration Modifies Behavioral and Brain Function in AdulthoodMark E Bardgett
Neurobiology of Learning and Memory|May 7, 2002
Kainic acid lesions disrupt fear-mediated memory processingHenry Yin, Mark E Bardgett, John G Csernansky
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2002
The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppressionMark E Bardgett, William M Humphrey, John G Csernansky
Behavioral Neuroscience|April 1, 2009
Dopamine modulates effort-based decision making in ratsMark E Bardgett, Melissa Depenbrock, Nathan Downs, et al.
Neuropharmacology|July 13, 2010
The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in ratsMark E Bardgett, Megan Points, Jennifer Kleier, et al.
Neurobiology of Learning and Memory|November 16, 2010
Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's diseaseMark E Bardgett, Natasha N Davis, Patrick J Schultheis, et al.
Psychopharmacology|May 26, 2009
Effects of the H(3) antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in ratsMark E Bardgett, Megan Points, John Roflow, et al.
European Journal of Pharmacology|July 19, 2017
Early-life risperidone enhances locomotor responses to amphetamine during adulthoodBobbie Lee Stubbeman, Clifford J Brown, Justin R Yates, et al.
Alcoholism, Clinical and Experimental Research|June 17, 2011
Effects of energy drinks mixed with alcohol on behavioral control: risks for college students consuming trendy cocktailsCecile A Marczinski, Mark T Fillmore, Mark E Bardgett, et al.
Behavioural Pharmacology|March 10, 2016
Delayed yet persistent effects of daily risperidone on activity in developing ratsRachel M Stevens, Matthew A Gannon, Molly S Griffith, et al.
Pageof 3